DOI QR코드

DOI QR Code

Adjusting for Confounders in Outcome Studies Using the Korea National Health Insurance Claim Database: A Review of Methods and Applications

  • Seung Jin Han (Review and Assessment Research Institute, Health Insurance Review & Assessment Service) ;
  • Kyoung Hoon Kim (International Policy Research Division, Health Insurance Review & Assessment Service)
  • 투고 : 2023.06.01
  • 심사 : 2023.10.30
  • 발행 : 2024.01.31

초록

Objectives: Adjusting for potential confounders is crucial for producing valuable evidence in outcome studies. Although numerous studies have been published using the Korea National Health Insurance Claim Database, no study has critically reviewed the methods used to adjust for confounders. This study aimed to review these studies and suggest methods and applications to adjust for confounders. Methods: We conducted a literature search of electronic databases, including PubMed and Embase, from January 1, 2021 to December 31, 2022. In total, 278 studies were retrieved. Eligibility criteria were published in English and outcome studies. A literature search and article screening were independently performed by 2 authors and finally, 173 of 278 studies were included. Results: Thirty-nine studies used matching at the study design stage, and 171 adjusted for confounders using regression analysis or propensity scores at the analysis stage. Of these, 125 conducted regression analyses based on the study questions. Propensity score matching was the most common method involving propensity scores. A total of 171 studies included age and/or sex as confounders. Comorbidities and healthcare utilization, including medications and procedures, were used as confounders in 146 and 82 studies, respectively. Conclusions: This is the first review to address the methods and applications used to adjust for confounders in recently published studies. Our results indicate that all studies adjusted for confounders with appropriate study designs and statistical methodologies; however, a thorough understanding and careful application of confounding variables are required to avoid erroneous results.

키워드

참고문헌

  1. Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol 2022;22(1):287. https://doi.org/10.1186/s12874-022-01768-6
  2. Jager KJ, Zoccali C, Macleod A, Dekker FW. Confounding: what it is and how to deal with it. Kidney Int 2008;73(3):256-260. https://doi.org/10.1038/sj.ki.5002650
  3. Kim DS, Kim HJ, Ahn HS. Association between statins and the risk of kidney cancer incidence and mortality using the Korean National Health Insurance Claims Database. Cancer Control 2022;29:10732748221111293. https://doi.org/10.1177/10732748221111293
  4. Oh J, Lee HS, Jeon S, Kim D, Seok JH, Park WC, et al. Risk of developing depression from endocrine treatment: a nationwide cohort study of women administered treatment for breast cancer in South Korea. Front Oncol 2022;12:980197. https://doi.org/10.3389/fonc.2022.980197
  5. Park JS, Lee CH. Clinical study using healthcare claims database. J Rheum Dis 2021;28(3):119-125. https://doi.org/10.4078/jrd.2021.28.3.119
  6. Kim H, Cho SI, Won S, Han Y, Kwon TW, Cho YP, et al. The prevalence of concomitant abdominal aortic aneurysm and cancer. J Clin Med 2021;10(17):3847. https://doi.org/10.3390/jcm10173847
  7. Choi H, Seo GH. Entecavir versus tenofovir for the prevention of hepatocellular carcinoma in treatment-naive chronic hepatitis B patients in Korea. J Korean Med Sci 2021;36(14):e89. https://doi.org/10.3346/jkms.2021.36.e89
  8. Yoon HJ, Kim JH, Seo GH, Park H. Risk of cancer following the use of N-nitrosodimethylamine (NDMA) contaminated ranitidine products: a nationwide cohort study in South Korea. J Clin Med 2021;10(1):153. https://doi.org/10.3390/jcm10010153
  9. Lee J, Huh KH, Yoon SR, Lee SY, Lee HS. Pregnancy outcomes after living kidney donation from a nationwide populationbased cohort study from Korea. Sci Rep 2022;12(1):22412. https://doi.org/0.1038/s41598-022-27094-x 1038/s41598-022-27094-x
  10. Kim K, Tsai AC, Lowe S, Stewart R, Jung SJ. Urbanicity, posttraumatic stress disorder, and effect modification by socioeconomic position: a nested case-control study of the Korean National Health Insurance Database. Acta Psychiatr Scand 2023;147(1):54-64. https://doi.org/10.1111/acps.13499
  11. Sohn SY, Seo GH, Chung JH. Risk of all-cause mortality in levothyroxine-treated hypothyroid patients: a nationwide Korean cohort study. Front Endocrinol (Lausanne) 2021;12:680647. https://doi.org/10.3389/fendo.2021.680647
  12. Kim M, Han K, Yoo SA, Lee JH. Herpes zoster and subsequent cancer risk: a nationwide population-based cohort study in Korea. Dermatology 2021;237(1):73-78. https://doi.org/10.1159/000505911
  13. Park EH, Lee JS, Kim YJ, Lee SM, Jun JK, Lee EB, et al. Pregnancy outcomes in Korean women with ankylosing spondylitis. Korean J Intern Med 2021;36(3):721-730. https://doi.org/10.3904/kjim.2019.144
  14. Jeong Y, Jung YJ, Noh E, Ha S, Hwang J, Cho GJ, et al. The risk for future cerebrovascular disease in pregnant women with Moyamoya disease: a nationwide population-based study in South Korea. BMC Pregnancy Childbirth 2022;22(1):433. https://doi.org/10.1186/s12884-022-04718-8
  15. Kim DS, Ahn HS, Kim HJ. Statin use and incidence and mortality of breast and gynecology cancer: a cohort study using the National Health Insurance claims database. Int J Cancer 2022;150(7):1156-1165. https://doi.org/10.1002/ijc.33869
  16. Austin PC, Xin Yu AY, Vyas MV, Kapral MK. Applying propensity score methods in clinical research in neurology. Neurology 2021;97(18):856-863. https://doi.org/10.1212/WNL.0000000000012777
  17. Park S, Han S, Suh HS. The disease burden of migraine patients receiving prophylactic treatments in Korea: a population-based claims database analysis. BMC Health Serv Res 2022;22(1):902. https://doi.org/10.1186/s12913-022-08191-z
  18. Han S, Han S, Suh HS, Bang OY, On YK, Lee MY, et al. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a nationwide, population-based study in Korea. J Arrhythm 2021;37(5):1240-1249. https://doi.org/10.1002/joa3.12607
  19. Chow R, Lee J, Noh H, Lee J, Simone CB 2nd, Shin HJ, et al. The association between statin and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea. Ann Palliat Med 2022;11(4):1297-1307. https://doi.org/10.21037/apm-21-3464
  20. Song Y, Lee HS, Park G, Kang SW, Lee JW. Dyslipidemia risk in thyroid cancer patients: a nationwide population-based cohort study. Front Endocrinol (Lausanne) 2022;13:893461. https://doi.org/10.3389/fendo.2022.893461
  21. Yun I, Hurh K, Jeong SH, Park EC, Jang SI. The risk of osteoporotic fractures after gastrectomy: findings from the Korean national sample cohort database (2002-2019). Front Oncol 2022;12:1014817. https://doi.org/10.3389/fonc.2022.1014817
  22. Kim EH, Lee J, Lee SA, Jung YW. Impact of maternal age on singleton pregnancy outcomes in primiparous women in South Korea. J Clin Med 2022;11(4):969. https://doi.org/10.3390/jcm11040969
  23. Ha EK, Kim JH, Kwak JH, Lee S, Cha HR, Chung EH, et al. Association of clinical and social factors with risk of fracture in children with atopic dermatitis. Pediatr Allergy Immunol 2022;33(2):e13712. https://doi.org/10.1111/pai.13712
  24. Oh TK, Song IA. Weekend admission and mortality among patients with sepsis: a nationwide cohort study in South Korea. Acta Anaesthesiol Scand 2021;65(5):639-647. https://doi.org/10.1111/aas.13786
  25. Biondi-Zoccai G, Romagnoli E, Agostoni P, Capodanno D, Castagno D, D'Ascenzo F, et al. Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials 2011;32(5):731-740. https://doi.org/10.1016/j.cct.2011.05.006
  26. Amoah J, Stuart EA, Cosgrove SE, Harris AD, Han JH, Lautenbach E, et al. Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data: a case study evaluating the treatment of gram-negative bloodstream infections. Clin Infect Dis 2020;71(9):e497-e505. https://doi.org/10.1093/cid/ciaa169
  27. Nguyen TL, Collins GS, Spence J, Daures JP, Devereaux PJ, Landais P, et al. Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol 2017;17(1):78. https://doi.org/10.1186/s12874-017-0338-0
  28. Kim KH. Comorbidity adjustment in health insurance claim database. Health Policy Manag 2016;26(1):71-78 (Korean). http://dx.doi.org/10.4332/KJHPA.2016.26.1.71
  29. Health Insurance Review and Assessment Service (HIRA). Manual for analysis of health insurance claim data to generate health care evidence. Wonju: HIRA; 2018, p. 34-45 (Korean).
  30. Kim KH, Ahn LS. A comparative study on comorbidity measurements with lookback period using health insurance database: focused on patients who underwent percutaneous coronary intervention. J Prev Med Public Health 2009;42(4):267-273 (Korean). https://doi.org/10.3961/jpmph.2009.42.4.267
  31. Kim KH. Comparative study on three algorithms of the ICD-10 Charlson comorbidity index with myocardial infarction patients. J Prev Med Public Health 2010;43(1):42-49 (Korean). https://doi.org/10.3961/jpmph.2010.43.1.42
  32. Kim J, Choi EY, Lee W, Oh HM, Pyo J, Ock M, et al. Feasibility of capturing adverse events from insurance claims data using International Classification of Diseases, tenth revision, codes coupled to present on admission indicators. J Patient Saf 2022;18(5):404-409. https://doi.org/10.1097/PTS.0000000000000932